You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

Patent: 7,304,033


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,304,033
Title:Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
Abstract: The present invention is a method of inhibiting islet cell transplant rejection, particularly to treat diabetes, such as type-1 and type-2 diabetes, by administering to a subject an effective amount of a soluble CTLA4 mutant molecule. One example of a soluble CTLA4 mutant molecule is L104EA29YIg.
Inventor(s): Larsen; Christian P. (Atlanta, GA), Pearson; Thomas C. (Atlanta, GA), Adams; Andrew B. (Atlanta, GA), Peach; Robert J. (San Diego, CA), Linsley; Peter S. (Seattle, WA), Naemura; Joseph Roy (Bellevue, WA), Bajorath; Jurgen (Bonn, DE)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:10/155,514
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 7,304,033

Introduction

United States Patent 7,304,033, issued on November 4, 2007, is a patent that has been the subject of various analyses and critiques, particularly in the context of patent landscape and claim validity. This article will delve into the claims of this patent, the broader patent landscape, and the critical aspects that have emerged from its examination.

Understanding the Patent

Patent Overview

The patent in question, US 7,304,033, is titled "Method and system for providing a web-based interactive voice response system" and was assigned to International Business Machines Corporation (IBM). The patent describes a method and system for integrating web-based and voice response technologies to enhance user interaction.

Claims Analysis

To analyze the claims of this patent, it is crucial to understand the specificity and breadth of the claims. Here are some key points:

  • Claim Scope: The claims must be specific enough to define the invention but broad enough to cover variations that would be obvious to those skilled in the art. For US 7,304,033, the claims need to be scrutinized for their clarity and the extent to which they cover the integration of web and voice response technologies.
  • Prior Art: A thorough search for prior art is essential to determine if the claims are novel and non-obvious. This involves using resources such as the USPTO's Patent Public Search tool, Global Dossier, and international patent databases to identify any existing patents or publications that may anticipate the claims[1].

Patent Landscape Analysis

Geographical Spread and Saturation

A comprehensive patent landscape analysis involves understanding the geographical spread and saturation of the technology area.

  • Geographical Spread: This involves identifying where the technology is being developed and patented. For voice response and web integration technologies, it is likely that patents are filed in various countries, including the United States, Europe, Japan, and China[1][3].
  • Saturation Level: Determining the saturation level helps in understanding the competitiveness and potential barriers to entry in this technology space. If the space is highly saturated, it may be challenging to secure broad claims, and alternative technologies might need to be explored[3].

Competitors and New Entrants

Identifying competitors and new entrants is crucial for strategic decision-making.

  • Competitors: Major players like IBM, Microsoft, and other tech giants may have significant patent portfolios in this area. Analyzing their patent filings and strategies can provide insights into market trends and potential areas of innovation[3].
  • New Entrants: New companies entering this space may bring fresh innovations or different approaches. Identifying these new entrants can help in anticipating future competition and potential collaboration opportunities[3].

Critical Aspects and Challenges

Patentability and Validity

The validity of the claims in US 7,304,033 can be challenged based on several grounds:

  • Novelty and Non-Obviousness: The claims must meet the requirements of novelty and non-obviousness. If prior art exists that anticipates the claims, the patent could be invalidated[5].
  • Subject Matter Eligibility: The Supreme Court's decisions, such as in the Mayo and Alice cases, have set a two-step test for determining subject matter eligibility. The claims must not fall within the judicial exceptions (laws of nature, natural phenomena, and abstract ideas) and must involve an inventive concept[5].

Litigation and Challenges

Patents like US 7,304,033 can be subject to various challenges, including:

  • Covered Business Method (CBM) Review: If the patent is challenged under the CBM program, it must withstand scrutiny for its validity. The CBM program has resulted in decisions against about one-third of the challenged patents between 2012 and 2017[2].
  • Inter Partes Review (IPR): This is another mechanism where the validity of the patent can be challenged. The process involves the Patent Trial and Appeal Board (PTAB) reviewing the patent claims for their validity based on prior art and other grounds.

Strategic Insights

Time-Slicing and Trend Analysis

Analyzing the patent landscape over time (time-slicing) can reveal trends and shifts in technology focus.

  • Abandoned Technologies: Identifying abandoned technologies can help in understanding where the industry is moving away from and where new opportunities might lie. For example, if a company has ceased filing patents in a particular area, it may indicate a shift in their strategic focus[3].

Niche Patent Areas

Identifying underappreciated niche patent areas can provide strategic advantages.

  • Focus on Niche Technologies: Companies focusing on niche technologies may have a significant portion of their patent portfolio dedicated to these areas. Identifying these niches can help in targeting specific markets or technologies that are less competitive[3].

Key Takeaways

  • Thorough Search: Conduct a thorough search for prior art using various resources to ensure the novelty and non-obviousness of the claims.
  • Landscape Analysis: Perform a comprehensive patent landscape analysis to understand the geographical spread, saturation level, and competitive landscape.
  • Validity Challenges: Be prepared for challenges to the patent's validity through mechanisms like CBM review and IPR.
  • Strategic Decisions: Use patent landscape analysis to guide strategic decisions on technology focus, market entry, and innovation.

FAQs

Q: What is the purpose of a patent landscape analysis? A: A patent landscape analysis helps in understanding the competitive landscape, identifying trends, and making strategic decisions about technology focus and market entry.

Q: How can I determine the saturation level of a technology area? A: By analyzing the number of patents filed in a specific technology area over time and identifying the key players and their patent portfolios.

Q: What is the Covered Business Method (CBM) review program? A: The CBM program allows entities facing patent infringement lawsuits to challenge the validity of business method patents by demonstrating that they do not meet the requirements for patentability.

Q: How do I search for prior art related to a patent? A: Use resources such as the USPTO's Patent Public Search tool, Global Dossier, and international patent databases to search for prior art.

Q: What are the key factors to consider when evaluating the validity of a patent claim? A: The claim must meet the requirements of novelty, non-obviousness, and subject matter eligibility, and must not fall within judicial exceptions.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. GAO - Assessment of the Covered Business Method Patent Review Program. Retrieved from https://www.gao.gov/products/gao-18-320
  3. AcclaimIP - Patent Landscape Analysis. Retrieved from https://www.acclaimip.com/patent-landscaping/patent-landscape-analysis-uncovering-strategic-insights/
  4. U.S. Department of Commerce - U.S. Patent and Trademark Office. Retrieved from https://www.commerce.gov/bureaus-and-offices/uspto
  5. USPTO - Patent Eligible Subject Matter: Report on Views and Recommendations. Retrieved from https://www.uspto.gov/sites/default/files/documents/101-Report_FINAL.pdf

More… ↓

⤷  Subscribe

Details for Patent 7,304,033

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bayer Healthcare Pharmaceuticals Inc. BETASERON interferon beta-1b For Injection 103471 July 23, 1993 7,304,033 2021-05-23
Biogen Inc. AVONEX interferon beta-1a For Injection 103628 May 17, 1996 7,304,033 2021-05-23
Biogen Inc. AVONEX interferon beta-1a Injection 103628 May 28, 2003 7,304,033 2021-05-23
Biogen Inc. AVONEX interferon beta-1a Injection 103628 February 27, 2012 7,304,033 2021-05-23
Kamada Ltd. WINRHO SD, WINRHO SDF LIQUID, WINRHO SDF LYOPHILIZED rho(d) immune globulin intravenous (human) For Injection 103649 April 02, 1996 7,304,033 2021-05-23
Kamada Ltd. WINRHO SD, WINRHO SDF LIQUID, WINRHO SDF LYOPHILIZED rho(d) immune globulin intravenous (human) Injection 103649 March 31, 2005 7,304,033 2021-05-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.